Our catalog related to treatment and diagnosis includes:
TREATMENT AND DIAGNOSIS
• INDUSTRIAL PROPERTY (Patents, utility models, and associated know-how):
| Code | Title | Type | Description | PDF – Technology Offerings |
|---|---|---|---|---|
| FCAD-21005 | Clinical panel with biomarkers for the detection of statin intolerance in patients at high cardiovascular risk | Diagnosis (cardiology) | Use of a miRNA panel as biomarkers for the detection of statin intolerance. |
Spanish English |
| FCAD-21002 | Organic compounds for the treatment of diabetic retinopathy and nephropathy | Therapy | A molecule with anti-inflammatory and chemopreventive potential in inflammatory processes in general, in diseases caused by underlying inflammatory processes, and in inflammatory processes related to the development of diabetes mellitus and its complications. |
Spanish English |
| UCA-P201800246 | Composition capable of promoting the formation of neurons in culture and in brain injuries | Therapy | This invention relates to the use of the compound EOF2 or a pharmacologically active salt of said compound to promote the differentiation of neural precursors or neural stem cells into neurons in culture and in brain injuries. Additionally, it relates to its use for the treatment of CNS injuries associated with neuronal loss. | ND |
| UCA-P201600138 | Use of Mango Leaf Extract for the Treatment of Neurodegenerative Diseases | Therapy | The present invention relates to the use of an extract for the preparation of a pharmaceutical or nutraceutical Composition useful in the treatment of CNS diseases characterized by inflammation. These are the most common forms of dementia and account for approximately 80% of cases. | Spanish (UCA website) |
| UCA-P201830615 | Methods for the diagnosis and/or treatment of neurodegenerative diseases | Diagnosis, Treatment | An in vitro method for detecting at least one neurodegenerative disease, for monitoring the efficacy of a treatment and/or for predicting the response to a treatment, and for identifying compound candidates useful for treatment. Furthermore, the present invention relates to therapeutic targets for use in the treatment of neurodegenerative diseases, as well as to compounds capable of inhibiting said therapeutic targets, with the aim of improving the health of patients suffering from a neurodegenerative disease. | ND |
| FCAD-21002 | Computer-implemented method for converting a high-resolution digital image into a DICOM pyramid image | ICT Diagnosis | A new computer-based method designed specifically to convert a high-resolution image—for example, an image obtained by scanning or digitizing a histological or cytological specimen in Pathology—from its original format to DICOM format. | ND |
| FCAD-23001 | Pharmacological inhibitors of the NLRP1 and NLRP3 inflammasomes | Therapy | Specific inhibitors that simultaneously block the NLRP1 and NLRP3 inflammatory complexes, reducing IL-1β- and IL-18-mediated inflammation with low cellular toxicity, for the treatment of inflammatory diseases. |
Spanish English |
| FCAD-23010 | Stabilized mixture based on natural sweeteners for the production of ice cream suitable for consumption by people with diabetes, manufacturing process, and uses | Research Model | A stabilized blend of natural sweeteners, based on tagatose, designed for making ice cream suitable for people with diabetes, while maintaining texture, flavor, and quality without affecting blood sugar levels. |
Spanish English |
| FCAD-24001 | Panel of protein markers for predicting cardiovascular events resulting from the atherosclerotic process | Personalized Medicine | A panel of protein biomarkers to predict the progression of atherosclerosis in patients with dyslipidemia, enabling more accurate risk stratification and personalized management of cardiovascular disease. |
Spanish English |
| FCAD-24002 | Development of modular and/or reversible chimeric antigen receptors (CARs) mediated by inteins | Therapy | Use of split antigens to improve industrial processes, such as the modular creation of CAR receptors that recognize multiple antigens, the evaluation of protein domains without expressing complete molecules, and the dynamic modulation of CAR activity through the controlled removal of active domains. |
Spanish English |
| INiBICA-25003 | Biomarkers for the Prediction and Diagnosis of Severe Atherosclerosis | Diagnosis (severe atherosclerosis) | A panel of protein biomarkers in blood designed to predict, provide early diagnosis, and guide the treatment of atherosclerotic cardiovascular diseases. |
Spanish English |
CODE: FCAD-21005
Title: Clinical panel with biomarkers for the detection of statin intolerance in patients at high cardiovascular risk
TYPE: Diagnostic (cardiology)
DESCRIPTION: Use of a miRNA panel as biomarkers for the detection of statin intolerance.
CODE: FCAD-21002
Title: Organic compounds for the treatment of diabetic retinopathy and nephropathy
TYPE: Therapy
DESCRIPTION: A molecule with anti-inflammatory and chemopreventive potential in inflammatory processes in general, in diseases caused by underlying inflammatory processes, and in inflammatory processes related to the development of diabetes mellitus and its complications.
CODE: UCA-P201800246
Title: Composition , which promotes the formation of neurons in culture and in brain injuries
TYPE: Therapy
DESCRIPTION: This invention relates to the use of the compound EOF2 or a pharmacologically active salt of said compound to promote the differentiation of neural precursors or neural stem cells into neurons in culture and in brain injuries. Additionally, it relates to its use for the treatment of CNS injuries associated with neuronal loss.
PDF - TECHNOLOGY OFFERING: ND
CODE: UCA-P201600138
Title: Use of mango leaf extract for the treatment of neurodegenerative diseases
TYPE: Therapy
DESCRIPTION: The present invention relates to the use of an extract for the preparation of a pharmaceutical or nutraceutical Composition useful in the treatment of CNS diseases characterized by inflammation. These are the most common forms of dementia and account for approximately 80% of cases.
PDF - TECHNOLOGY OFFERINGS: Spanish (UCA website)
CODE: UCA-P201830615
Title: Methods for the diagnosis and/or treatment of neurodegenerative diseases
TYPE: Diagnosis, Treatment
DESCRIPTION: An in vitro method for detecting at least one neurodegenerative disease, for monitoring the efficacy of a treatment and/or for predicting the response to a treatment, and for identifying compound candidates useful for treatment. Furthermore, the present invention relates to therapeutic targets for use in the treatment of neurodegenerative diseases, as well as to compounds capable of inhibiting said therapeutic targets with the aim of improving the health of patients suffering from a neurodegenerative disease.
PDF - TECHNOLOGY OFFERING: ND
CODE: FCAD-17001
Title: A computer-based method for converting a high-resolution digital image into a DICOM pyramid image
TYPE: ICT Diagnosis
DESCRIPTION: A new computer-based method designed specifically to convert a high-resolution image—for example, an image obtained by scanning or digitizing a histological or cytological specimen in Pathology—from its original format to DICOM format.
PDF - TECHNOLOGY OFFERING: ND
CODE: FCAD-23001
Title: Pharmacological inhibitors of the NLRP1 and NLRP3 inflammasomes
TYPE: Therapy
DESCRIPTION: Specific inhibitors that simultaneously block the NLRP1 and NLRP3 inflammatory complexes, reducing IL-1β- and IL-18-mediated inflammation with low cellular toxicity, for the treatment of inflammatory diseases.
CODE: FCAD-23010
Title: Stabilized mixture based on natural sweeteners for the production of ice cream suitable for consumption by people with diabetes, manufacturing process, and uses
TYPE: Research model
DESCRIPTION: A stabilized blend of natural sweeteners, based on tagatose, designed for making ice cream suitable for people with diabetes, while maintaining texture, flavor, and quality without affecting blood sugar levels.
CODE: FCAD-24001
Title: Panel of protein markers for predicting cardiovascular events resulting from the atherosclerotic process
TYPE: Personalized Medicine
DESCRIPTION: A panel of protein biomarkers to predict the progression of atherosclerosis in patients with dyslipidemia, enabling more accurate risk stratification and personalized management of cardiovascular disease.
CODE: FCAD-24002
Title: Development of modular and/or reversible chimeric antigen receptors (CARs) mediated by inteins
TYPE: Therapy
DESCRIPTION: Use of split inteins to improve industrial processes, such as the modular construction of CAR receptors that recognize multiple antigens, the evaluation of protein domains without expressing complete molecules, and the dynamic modulation of CAR activity through the controlled removal of active domains.
CODE: INiBICA-25003
Title: Biomarkers for the Prediction and Diagnosis of Severe Atherosclerosis
TYPE: Diagnosis (severe atherosclerosis)
DESCRIPTION: A panel of blood-based protein biomarkers designed to predict, provide early diagnosis, and guide the treatment of atherosclerotic cardiovascular diseases.
• INTELLECTUAL PROPERTY (know-how, software, app):
| Code | Title | Type | Description | PDF – Technology Offerings |
|---|---|---|---|---|
| FCAD-22002 | MELAGE | Diagnostic software | Software that facilitates the viewing and management of ultrasound and MRI scans of newborns' brains to improve the early diagnosis of motor and cognitive impairments. |
Spanish English |
CODE: FCAD-22002
Title: MELAGE
TYPE: Diagnostic software
DESCRIPTION: Software that facilitates the viewing and management of ultrasound and brain MRI images of newborns to improve the early diagnosis of motor and cognitive impairments.
If you have any trouble downloading the file mentioned above, you can access it via the following link.